Bioceres Crop Solutions (NASDAQ:BIOX) Given New $10.00 Price Target at Canaccord Genuity Group

Bioceres Crop Solutions (NASDAQ:BIOXFree Report) had its price target trimmed by Canaccord Genuity Group from $12.50 to $10.00 in a research note published on Thursday, Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other research analysts have also recently issued reports on the stock. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Oppenheimer dropped their price objective on Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating for the company in a research report on Wednesday, September 11th. Roth Capital raised Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Roth Mkm reduced their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Finally, Lake Street Capital dropped their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Four research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $13.00.

Get Our Latest Stock Analysis on BIOX

Bioceres Crop Solutions Stock Performance

Shares of BIOX opened at $7.38 on Thursday. The company has a current ratio of 1.28, a quick ratio of 0.91 and a debt-to-equity ratio of 0.35. Bioceres Crop Solutions has a 12 month low of $7.15 and a 12 month high of $14.05. The firm has a fifty day simple moving average of $8.97 and a 200 day simple moving average of $10.58. The stock has a market capitalization of $463.44 million, a price-to-earnings ratio of 738.00 and a beta of 0.47.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last announced its quarterly earnings data on Monday, September 9th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). The firm had revenue of $124.30 million during the quarter, compared to the consensus estimate of $126.75 million. Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. During the same period last year, the business earned ($0.06) EPS. Research analysts forecast that Bioceres Crop Solutions will post 0.39 EPS for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several large investors have recently made changes to their positions in the business. Oak Family Advisors LLC boosted its holdings in Bioceres Crop Solutions by 1.9% in the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after purchasing an additional 1,208 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after purchasing an additional 5,341 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Bioceres Crop Solutions by 3.1% in the 4th quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock worth $3,253,000 after buying an additional 7,096 shares during the last quarter. Oppenheimer & Co. Inc. bought a new stake in Bioceres Crop Solutions in the first quarter valued at $139,000. Finally, Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions during the 1st quarter valued at about $212,000. 17.68% of the stock is owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

See Also

Analyst Recommendations for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.